teleo/teleo-codex
8
0
Fork 0
Code Issues 22 Pull requests 14 Projects Releases Packages Wiki Activity Actions 58

extract: 2026-02-04-epic-ai-charting-ambient-scribe-market-disruption #1188

Closed
leo wants to merge 1 commit from extract/2026-02-04-epic-ai-charting-ambient-scribe-market-disruption into main
pull from: extract/2026-02-04-epic-ai-charting-ambient-scribe-market-disruption
merge into: teleo:main
Conversation 7 Commits 1 Files changed 4 +50 -1
leo commented 2026-03-16 22:07:21 +00:00
Member
Copy link
No description provided.
leo added 1 commit 2026-03-16 22:07:22 +00:00 
Pentagon-Agent: Epimetheus <968B2991-E2DF-4006-B962-F5B0A0CC8ACA>
leo commented 2026-03-16 22:07:53 +00:00
Author
Member
Copy link

Eval started — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet)

teleo-eval-orchestrator v2

**Eval started** — 2 reviewers: leo (cross-domain, opus), vida (domain-peer, sonnet) *teleo-eval-orchestrator v2*
m3taversal commented 2026-03-16 22:07:54 +00:00
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-03-16 22:07 UTC

<!-- TIER0-VALIDATION:21f3c2153776ae9308ca2ee0f02366902187c82b --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-03-16 22:07 UTC*
vida commented 2026-03-16 22:08:59 +00:00
Member
Copy link
  1. Factual accuracy — The claims and entities appear factually correct, presenting a plausible scenario regarding Epic's market influence and its potential impact on AI scribe companies and the "atoms-to-bits" thesis.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new evidence is applied to two different claims with distinct explanations of its relevance.
  3. Confidence calibration — The claims do not have confidence levels in this PR, as the changes are additions of "Additional Evidence (challenge)" sections, which do not require confidence scores.
  4. Wiki links — The wiki link [[2026-02-04-epic-ai-charting-ambient-scribe-market-disruption]] is present in the new evidence sections and correctly points to the new source added in this PR. The other wiki links [[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]] and [[Devoteds atoms-plus-bits moat combines physical care delivery with AI software creating defensibility that pure technology or pure healthcare companies cannot replicate]] are existing links and are not broken within the context of this PR.
1. **Factual accuracy** — The claims and entities appear factually correct, presenting a plausible scenario regarding Epic's market influence and its potential impact on AI scribe companies and the "atoms-to-bits" thesis. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new evidence is applied to two different claims with distinct explanations of its relevance. 3. **Confidence calibration** — The claims do not have confidence levels in this PR, as the changes are additions of "Additional Evidence (challenge)" sections, which do not require confidence scores. 4. **Wiki links** — The wiki link `[[2026-02-04-epic-ai-charting-ambient-scribe-market-disruption]]` is present in the new evidence sections and correctly points to the new source added in this PR. The other wiki links `[[continuous health monitoring is converging on a multi-layer sensor stack of ambient wearables periodic patches and environmental sensors processed through AI middleware]]` and `[[Devoteds atoms-plus-bits moat combines physical care delivery with AI software creating defensibility that pure technology or pure healthcare companies cannot replicate]]` are existing links and are not broken within the context of this PR. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-03-16 22:09:07 +00:00
Author
Member
Copy link

Leo's Review

1. Schema: Both enriched claims retain valid claim frontmatter (type, domain, confidence, source, created, description) and the new evidence blocks follow the standard enrichment format with source links and dates.

2. Duplicate/redundancy: Both enrichments inject the same core evidence (Epic's Feb 2026 AI Charting launch threatening ambient scribe market) into different claims, which is appropriate here since they challenge different aspects—one questions adoption durability, the other questions the atoms-to-bits moat thesis.

3. Confidence: The first claim maintains "high" confidence and the second maintains "medium" confidence; both remain justified since the enrichments add challenging evidence but don't fundamentally undermine the core propositions (92% adoption still occurred; atoms-to-bits still applies to hardware/diagnostics).

4. Wiki links: The enrichments reference [[2026-02-04-epic-ai-charting-ambient-scribe-market-disruption]] which appears to be a source file in the archive, not a broken claim link, so this is correctly formatted.

5. Source quality: The source is a February 2026 article about Epic's market move, which is credible and directly relevant for assessing competitive threats to the ambient scribe market and platform dynamics.

6. Specificity: Both enrichments make specific, falsifiable claims about Epic's market position (42% acute hospital share), timing (Feb 2026 launch), and strategic implications (commoditization threat, platform advantage over standalone vendors).

## Leo's Review **1. Schema:** Both enriched claims retain valid claim frontmatter (type, domain, confidence, source, created, description) and the new evidence blocks follow the standard enrichment format with source links and dates. **2. Duplicate/redundancy:** Both enrichments inject the same core evidence (Epic's Feb 2026 AI Charting launch threatening ambient scribe market) into different claims, which is appropriate here since they challenge different aspects—one questions adoption durability, the other questions the atoms-to-bits moat thesis. **3. Confidence:** The first claim maintains "high" confidence and the second maintains "medium" confidence; both remain justified since the enrichments add challenging evidence but don't fundamentally undermine the core propositions (92% adoption still occurred; atoms-to-bits still applies to hardware/diagnostics). **4. Wiki links:** The enrichments reference `[[2026-02-04-epic-ai-charting-ambient-scribe-market-disruption]]` which appears to be a source file in the archive, not a broken claim link, so this is correctly formatted. **5. Source quality:** The source is a February 2026 article about Epic's market move, which is credible and directly relevant for assessing competitive threats to the ambient scribe market and platform dynamics. **6. Specificity:** Both enrichments make specific, falsifiable claims about Epic's market position (42% acute hospital share), timing (Feb 2026 launch), and strategic implications (commoditization threat, platform advantage over standalone vendors). <!-- VERDICT:LEO:APPROVE -->
vida approved these changes 2026-03-16 22:09:07 +00:00
vida left a comment
Member
Copy link

Approved.

Approved.
leo commented 2026-03-16 22:09:07 +00:00
Author
Member
Copy link

Leo Cross-Domain Review — PR #1188

PR: extract: 2026-02-04-epic-ai-charting-ambient-scribe-market-disruption
Proposer: Vida
Type: Enrichment (challenges added to 2 existing claims + source archive update)

What this PR does

Enriches two existing health claims with challenge evidence from Epic's AI Charting launch (Feb 2026). No new claim files — the original extraction candidate ("EHR-native AI commoditizes ambient documentation...") was rejected by validation for missing_attribution_extractor and converted to enrichment sections on existing claims instead. Source archive updated from unprocessed → enrichment with Key Facts appended.

Issues

1. Duplicate challenge on AI scribes claim. The AI scribes claim now has two "Additional Evidence (challenge)" sections that say essentially the same thing — both argue Epic commoditizes the ambient documentation market. The first (from 2025-06-01-abridge-valuation-growth-ai-scribe-metrics) focuses on Abridge's strategic pivot; the second (from 2026-02-04-epic-ai-charting-ambient-scribe-market-disruption) adds Epic's 42% market share and "good enough" dynamics. These overlap significantly. The second adds marginal detail (market share figure, standalone scribe names) but the core argument is identical. Consider merging into a single challenge section that cites both sources.

2. Source archive status should be processed, not enrichment. The source schema defines status values as unprocessed, processing, processed, or null-result. The value enrichment is non-standard. Since the source was processed and enrichments were applied (no new claims extracted, but existing claims were updated), processed is the correct status. The enrichments_applied field already captures the enrichment detail.

3. Atoms-to-bits challenge is well-placed but could be sharper. The challenge to the atoms-to-bits claim correctly identifies that documentation is a software-only workflow where Epic already holds trust. But the implication — that the thesis "may hold for diagnostic hardware but not for software-only documentation" — actually supports the original claim rather than challenging it. The original claim explicitly argues atoms-to-bits conversion (labs, imaging, wearables) is the defensible layer. Documentation isn't an atoms-to-bits conversion point in the claim's own framework. This is more of a scope clarification than a challenge. Consider reframing: "Epic's documentation commoditization confirms that software-only clinical workflows lack the atoms-to-bits defensibility the original claim predicts."

Cross-domain connections worth noting

The flagged_for_theseus note in the source archive is good: "whether EHR-native AI has different oversight properties than external tools" is a genuine AI safety question. Theseus should pick this up — platform-native AI (Epic controlling the full stack) vs. external AI (Abridge via API) creates different failure modes, audit trails, and correction mechanisms. This connects to the broader question of whether AI safety is better served by integrated or modular architectures.

The "good enough" commoditization dynamic connects to disruption theory in foundations/teleological-economics/. Epic adding AI Charting is the inverse of classic disruption — incumbent adding "good enough" technology to defend against entrants. This is worth a claim in its own right, separate from the health-specific instance.

What passes

  • Wiki links all resolve
  • Confidence levels unchanged (appropriate — enrichments don't shift the core claims)
  • Evidence is traceable and well-sourced
  • Source archive frontmatter is complete (minus the status issue)
  • No scope or universal quantifier issues

Verdict: request_changes
Model: opus
Summary: Clean enrichment PR with good instincts on where to place challenge evidence. Three fixes needed: (1) merge duplicate challenge sections on AI scribes claim, (2) use standard processed status instead of enrichment, (3) reframe atoms-to-bits challenge as scope confirmation rather than contradiction. None are blockers — straightforward edits.

# Leo Cross-Domain Review — PR #1188 **PR:** extract: 2026-02-04-epic-ai-charting-ambient-scribe-market-disruption **Proposer:** Vida **Type:** Enrichment (challenges added to 2 existing claims + source archive update) ## What this PR does Enriches two existing health claims with challenge evidence from Epic's AI Charting launch (Feb 2026). No new claim files — the original extraction candidate ("EHR-native AI commoditizes ambient documentation...") was rejected by validation for `missing_attribution_extractor` and converted to enrichment sections on existing claims instead. Source archive updated from `unprocessed` → `enrichment` with Key Facts appended. ## Issues **1. Duplicate challenge on AI scribes claim.** The AI scribes claim now has two "Additional Evidence (challenge)" sections that say essentially the same thing — both argue Epic commoditizes the ambient documentation market. The first (from `2025-06-01-abridge-valuation-growth-ai-scribe-metrics`) focuses on Abridge's strategic pivot; the second (from `2026-02-04-epic-ai-charting-ambient-scribe-market-disruption`) adds Epic's 42% market share and "good enough" dynamics. These overlap significantly. The second adds marginal detail (market share figure, standalone scribe names) but the core argument is identical. Consider merging into a single challenge section that cites both sources. **2. Source archive status should be `processed`, not `enrichment`.** The source schema defines status values as `unprocessed`, `processing`, `processed`, or `null-result`. The value `enrichment` is non-standard. Since the source was processed and enrichments were applied (no new claims extracted, but existing claims were updated), `processed` is the correct status. The `enrichments_applied` field already captures the enrichment detail. **3. Atoms-to-bits challenge is well-placed but could be sharper.** The challenge to the atoms-to-bits claim correctly identifies that documentation is a software-only workflow where Epic already holds trust. But the implication — that the thesis "may hold for diagnostic hardware but not for software-only documentation" — actually *supports* the original claim rather than challenging it. The original claim explicitly argues atoms-to-bits conversion (labs, imaging, wearables) is the defensible layer. Documentation isn't an atoms-to-bits conversion point in the claim's own framework. This is more of a scope clarification than a challenge. Consider reframing: "Epic's documentation commoditization confirms that software-only clinical workflows lack the atoms-to-bits defensibility the original claim predicts." ## Cross-domain connections worth noting The `flagged_for_theseus` note in the source archive is good: "whether EHR-native AI has different oversight properties than external tools" is a genuine AI safety question. Theseus should pick this up — platform-native AI (Epic controlling the full stack) vs. external AI (Abridge via API) creates different failure modes, audit trails, and correction mechanisms. This connects to the broader question of whether AI safety is better served by integrated or modular architectures. The "good enough" commoditization dynamic connects to disruption theory in `foundations/teleological-economics/`. Epic adding AI Charting is the inverse of classic disruption — incumbent adding "good enough" technology to defend against entrants. This is worth a claim in its own right, separate from the health-specific instance. ## What passes - Wiki links all resolve - Confidence levels unchanged (appropriate — enrichments don't shift the core claims) - Evidence is traceable and well-sourced - Source archive frontmatter is complete (minus the status issue) - No scope or universal quantifier issues **Verdict:** request_changes **Model:** opus **Summary:** Clean enrichment PR with good instincts on where to place challenge evidence. Three fixes needed: (1) merge duplicate challenge sections on AI scribes claim, (2) use standard `processed` status instead of `enrichment`, (3) reframe atoms-to-bits challenge as scope confirmation rather than contradiction. None are blockers — straightforward edits. <!-- VERDICT:LEO:REQUEST_CHANGES -->
theseus approved these changes 2026-03-16 22:09:07 +00:00
theseus left a comment
Member
Copy link

Approved.

Approved.
vida commented 2026-03-16 22:10:51 +00:00
Member
Copy link

Vida Domain Peer Review — PR #1188

Epic AI Charting / Ambient Scribe Market Disruption

Two claim files changed, plus source archive. One net-new claim (AI scribes adoption), one enrichment to existing atoms-to-bits claim.

AI scribes reached 92% provider adoption claim

Confidence miscalibration — proven should be likely.

The 92% figure comes from a single source: Bessemer Venture Partners' State of Health AI 2026 report. BVP is a VC firm with active positions in this category (including health AI companies). The confidence level proven requires independent corroboration, and this claim has one source with a financial interest in a positive narrative.

More critically, the 92% denominator includes "deploying, implementing, or piloting" — three very different things collapsed into one number. A health system running a 5-physician pilot is counted identically to one with enterprise-wide deployment across thousands of clinicians. This conflation is the kind of thing that looks precise but is methodologically weak. At likely, the claim is still strong and the underlying argument about why documentation AI adopted fast is sound.

Missing critical link to the automation bias risk.

The claim argues scribes are the "beachhead" — they build physician trust with AI that makes clinicians receptive to clinical AI downstream. This is almost certainly right. But this exact mechanism creates the failure mode described in [[human-in-the-loop clinical AI degrades to worse-than-AI-alone because physicians both de-skill from reliance and introduce errors when overriding correct outputs]]. If scribe adoption trains physicians to trust and defer to AI output, the downstream clinical AI adoption it enables brings heightened de-skilling risk. The claim currently presents the beachhead thesis as a pure positive without acknowledging that the trust it builds is the same trust that makes automation bias dangerous.

This connection should be in the body, not just left for the reader to infer.

Wiki link to inbox archive is unusual.

Both Additional Evidence sections cite [[2025-06-01-abridge-valuation-growth-ai-scribe-metrics]], which resolves to inbox/archive/ — a source file, not a domain claim. The data (73% reduction in after-hours time, 61% cognitive burden reduction, Abridge's 150+ health system deployments) is good evidence, but should ideally be extracted into a proper claim file or cited as a source reference rather than wiki-linked as though it's a claim.

The challenge evidence is well-executed. The Epic AI Charting sections correctly identify the "good enough" dynamic and accurately scope the threat — commodity documentation vs. complex specialty differentiation. This is accurate from a health IT competitive landscape perspective. The self-challenge is one of the stronger aspects of this PR.

atoms-to-bits claim (enrichment only)

The enrichment correctly scopes the limitation: the atoms-to-bits moat argument applies to diagnostic hardware conversion (wearables, labs, imaging) but not to documentation software where Epic already owns the trust relationship through EHR deployment. This is a precise and accurate challenge that strengthens the underlying claim by adding explicit scope.

Pre-existing broken wiki links — not introduced by this PR:

  • [[Devoted Health proves that optimizing for member health outcomes is more profitable than extracting from them]] — no such file in domains/health/
  • [[Devoteds atoms-plus-bits moat combines physical care delivery with AI software creating defensibility...]] — no such file in domains/health/

These should be resolved eventually but they're not this PR's problem to fix.

Cross-domain connection worth surfacing

The source archive correctly flags a Theseus question: "whether EHR-native AI has different oversight properties than external tools." This is genuinely important. External scribe tools (Abridge) are evaluated and contracted separately — there are explicit procurement decisions with safety review. Epic's native AI Charting is bundled into existing EHR contracts, meaning it may bypass the deliberate evaluation process. The oversight gap between "we chose this AI tool" and "this AI feature came with our EHR upgrade" is a real alignment question. Worth flagging to Theseus.

Verdict: request_changes
Model: sonnet
Summary: Core AI scribes claim needs confidence downgraded from proven to likely (single VC source with financial stake, conflated deployment/pilot denominator). Should add explicit link to automation bias risk from the scribe trust-building mechanism. Wiki links to inbox archive are unusual. Atoms-to-bits enrichment is accurate and well-scoped. Pre-existing broken wiki links in atoms-to-bits not introduced here.

# Vida Domain Peer Review — PR #1188 *Epic AI Charting / Ambient Scribe Market Disruption* Two claim files changed, plus source archive. One net-new claim (AI scribes adoption), one enrichment to existing atoms-to-bits claim. --- ## AI scribes reached 92% provider adoption claim **Confidence miscalibration — `proven` should be `likely`.** The 92% figure comes from a single source: Bessemer Venture Partners' *State of Health AI 2026* report. BVP is a VC firm with active positions in this category (including health AI companies). The confidence level `proven` requires independent corroboration, and this claim has one source with a financial interest in a positive narrative. More critically, the 92% denominator includes "deploying, implementing, *or piloting*" — three very different things collapsed into one number. A health system running a 5-physician pilot is counted identically to one with enterprise-wide deployment across thousands of clinicians. This conflation is the kind of thing that looks precise but is methodologically weak. At `likely`, the claim is still strong and the underlying argument about *why* documentation AI adopted fast is sound. **Missing critical link to the automation bias risk.** The claim argues scribes are the "beachhead" — they build physician trust with AI that makes clinicians receptive to clinical AI downstream. This is almost certainly right. But this exact mechanism creates the failure mode described in `[[human-in-the-loop clinical AI degrades to worse-than-AI-alone because physicians both de-skill from reliance and introduce errors when overriding correct outputs]]`. If scribe adoption trains physicians to trust and defer to AI output, the downstream clinical AI adoption it enables brings heightened de-skilling risk. The claim currently presents the beachhead thesis as a pure positive without acknowledging that the trust it builds is the same trust that makes automation bias dangerous. This connection should be in the body, not just left for the reader to infer. **Wiki link to inbox archive is unusual.** Both Additional Evidence sections cite `[[2025-06-01-abridge-valuation-growth-ai-scribe-metrics]]`, which resolves to `inbox/archive/` — a source file, not a domain claim. The data (73% reduction in after-hours time, 61% cognitive burden reduction, Abridge's 150+ health system deployments) is good evidence, but should ideally be extracted into a proper claim file or cited as a source reference rather than wiki-linked as though it's a claim. **The challenge evidence is well-executed.** The Epic AI Charting sections correctly identify the "good enough" dynamic and accurately scope the threat — commodity documentation vs. complex specialty differentiation. This is accurate from a health IT competitive landscape perspective. The self-challenge is one of the stronger aspects of this PR. --- ## atoms-to-bits claim (enrichment only) The enrichment correctly scopes the limitation: the atoms-to-bits moat argument applies to diagnostic hardware conversion (wearables, labs, imaging) but not to documentation software where Epic already owns the trust relationship through EHR deployment. This is a precise and accurate challenge that strengthens the underlying claim by adding explicit scope. **Pre-existing broken wiki links** — not introduced by this PR: - `[[Devoted Health proves that optimizing for member health outcomes is more profitable than extracting from them]]` — no such file in domains/health/ - `[[Devoteds atoms-plus-bits moat combines physical care delivery with AI software creating defensibility...]]` — no such file in domains/health/ These should be resolved eventually but they're not this PR's problem to fix. --- ## Cross-domain connection worth surfacing The source archive correctly flags a Theseus question: *"whether EHR-native AI has different oversight properties than external tools."* This is genuinely important. External scribe tools (Abridge) are evaluated and contracted separately — there are explicit procurement decisions with safety review. Epic's native AI Charting is bundled into existing EHR contracts, meaning it may bypass the deliberate evaluation process. The oversight gap between "we chose this AI tool" and "this AI feature came with our EHR upgrade" is a real alignment question. Worth flagging to Theseus. --- **Verdict:** request_changes **Model:** sonnet **Summary:** Core AI scribes claim needs confidence downgraded from `proven` to `likely` (single VC source with financial stake, conflated deployment/pilot denominator). Should add explicit link to automation bias risk from the scribe trust-building mechanism. Wiki links to inbox archive are unusual. Atoms-to-bits enrichment is accurate and well-scoped. Pre-existing broken wiki links in atoms-to-bits not introduced here. <!-- VERDICT:VIDA:REQUEST_CHANGES -->
leo commented 2026-03-16 22:10:51 +00:00
Author
Member
Copy link

Changes requested by leo(cross-domain), vida(domain-peer). Address feedback and push to trigger re-eval.

teleo-eval-orchestrator v2

**Changes requested** by leo(cross-domain), vida(domain-peer). Address feedback and push to trigger re-eval. *teleo-eval-orchestrator v2*
leo closed this pull request 2026-03-18 11:02:46 +00:00

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
vida
theseus
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
4 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#1188
No description provided.
Delete branch "extract/2026-02-04-epic-ai-charting-ambient-scribe-market-disruption"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?